ES480894A1 - Procedimiento para la preparacion de derivados de tiadiazol. - Google Patents

Procedimiento para la preparacion de derivados de tiadiazol.

Info

Publication number
ES480894A1
ES480894A1 ES480894A ES480894A ES480894A1 ES 480894 A1 ES480894 A1 ES 480894A1 ES 480894 A ES480894 A ES 480894A ES 480894 A ES480894 A ES 480894A ES 480894 A1 ES480894 A1 ES 480894A1
Authority
ES
Spain
Prior art keywords
alkyl
antisecretory
manufacture
processes
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES480894A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Zeneca Inc
Original Assignee
Imperial Chemical Industries Ltd
ICI Americas Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd, ICI Americas Inc filed Critical Imperial Chemical Industries Ltd
Publication of ES480894A1 publication Critical patent/ES480894A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Dental Preparations (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Procedimiento para preparar derivados de tiadiazol que son antagónicos H-2 a la histamina y que exhiben la secreción de ácido gástrico. Se postula que la histamina compuesta fisiológicamente activa que ocurre naturalmente dentro del cuerpo de un animal puede combinarse, mientras ejerce su actividad, con ciertos receptores específicos, de los cuales existen por lo menos dos tipos diferentes y separados. El primero se ha llamado al receptor H-1, y la acción de la histamina en este receptor histamínico ha sido llamado al receptor H-2, y la acción de la histamina en este receptor es bloqueada por drogas tales como la cimetidina. Se sabe que uno de los resultados del bloqueo de la acción histamínica en el receptor H-2 es que inhibe la secreción de ácido gástrico y, por lo tanto, un compuesto que posee esta capacidad es útil en el tratamiento de úlceras pépticas y otras condiciones causadas o exacerbadas por la acidez gástrica.
ES480894A 1978-05-24 1979-05-24 Procedimiento para la preparacion de derivados de tiadiazol. Expired ES480894A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2173778 1978-05-24

Publications (1)

Publication Number Publication Date
ES480894A1 true ES480894A1 (es) 1980-02-01

Family

ID=10167957

Family Applications (3)

Application Number Title Priority Date Filing Date
ES480894A Expired ES480894A1 (es) 1978-05-24 1979-05-24 Procedimiento para la preparacion de derivados de tiadiazol.
ES484149A Expired ES484149A1 (es) 1978-05-24 1979-09-13 Procedimiento para la preparacion de un derivado de tiadia- zol
ES484150A Expired ES484150A1 (es) 1978-05-24 1979-09-13 Procedimiento para la preparacion de derivados de tiadiazol

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES484149A Expired ES484149A1 (es) 1978-05-24 1979-09-13 Procedimiento para la preparacion de un derivado de tiadia- zol
ES484150A Expired ES484150A1 (es) 1978-05-24 1979-09-13 Procedimiento para la preparacion de derivados de tiadiazol

Country Status (22)

Country Link
US (2) US4242350A (es)
EP (1) EP0006679B1 (es)
JP (1) JPS54160376A (es)
AT (1) ATE1353T1 (es)
AU (1) AU529253B2 (es)
CA (1) CA1124729A (es)
CS (2) CS207790B2 (es)
DD (1) DD143772A5 (es)
DE (1) DE2963363D1 (es)
DK (1) DK209079A (es)
ES (3) ES480894A1 (es)
FI (1) FI791656A (es)
GR (1) GR73611B (es)
HU (1) HU179492B (es)
IE (1) IE48221B1 (es)
IL (1) IL57388A0 (es)
NO (1) NO791710L (es)
NZ (1) NZ190448A (es)
PL (1) PL118387B1 (es)
PT (1) PT69651A (es)
SU (1) SU1037839A3 (es)
ZA (1) ZA792202B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE1353T1 (de) * 1978-05-24 1982-08-15 Imperial Chemical Industries Plc Anti-sekretion thiadiazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3069889D1 (en) * 1979-01-18 1985-02-14 Ici Plc Guanidine derivatives, processes for their manufacture and pharmaceutical compositions containing them
GR71929B (es) * 1979-11-13 1983-08-19 Ici Ltd
US4375547A (en) * 1980-10-02 1983-03-01 Eli Lilly And Company N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine
DE3270716D1 (en) * 1981-02-27 1986-05-28 Ici Plc Guanidino-substituted heterocyclic derivatives having histamine h-2 antagonist activity
CA1209998A (en) * 1981-03-09 1986-08-19 David J. Gilman Amide derivatives as histamine h-2 receptor antagonists
CA1233818A (en) * 1981-03-09 1988-03-08 David J. Gilman Guanidine derivatives as histamine h-2 receptor antagonists
US4460584A (en) * 1981-03-13 1984-07-17 Imperial Chemical Industries Plc Nitrogen heterocycles
US4463005A (en) * 1981-03-18 1984-07-31 Imperial Chemical Industries Plc Bicyclic guanidines
IN158869B (es) * 1981-03-18 1987-02-07 Ici Plc
US4451463A (en) * 1981-03-24 1984-05-29 Imperial Chemical Industries Plc Alcohol derivatives
EP0065823A1 (en) * 1981-05-13 1982-12-01 Imperial Chemical Industries Plc Heterocyclic guanidines as histamine H-2 antagonists
US4607105A (en) * 1981-05-18 1986-08-19 Bristol-Myers Company 3-cyclobutene-1,2-dione intermediates
US4522943A (en) * 1981-05-18 1985-06-11 Bristol-Myers Company Chemical compounds
US4546188A (en) * 1981-05-18 1985-10-08 Bristol-Myers Company Substituted 1,2-diaminocyclobutene-3,4-diones
US4539316A (en) * 1981-05-18 1985-09-03 Bristol-Myers Company Pyridine derivatives of 1,2-diaminocyclobutene-3,4-diones
US4526973A (en) * 1981-05-18 1985-07-02 Bristol-Myers Company Chemical compounds
US4395553A (en) * 1981-05-18 1983-07-26 Bristol-Myers Company Chemical compounds
DE3267110D1 (de) * 1981-05-18 1985-12-05 Ici Plc Amidine derivatives
US4390701A (en) * 1981-05-18 1983-06-28 Bristol-Myers Company 1-Amino-2-[3-(3-piperidinomethylphenoxy)propylamino]cyclobutene-3,4-dione
GB8419223D0 (en) * 1984-07-27 1984-08-30 Hoechst Uk Ltd Sulphamoylguanidine derivatives
JPS60255756A (ja) * 1984-06-01 1985-12-17 Ikeda Mohandou:Kk アミノアルキルフエノキシ誘導体
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE842346C (de) * 1950-10-14 1952-06-26 Joachim Dipl-Chem Dr Goerdeler Verfahren zur Darstellung von 5-Amino-1, 2, 4-thiodiazolen
DE955684C (de) * 1953-10-14 1957-01-10 Bayer Ag Verfahren zur Herstellung von 5-Amino-1, 2, 4-thiodiazolen
NL266116A (es) 1960-06-22
BE758146A (fr) 1969-10-29 1971-04-28 Smith Kline French Lab Derives de l'amidine
GB1305549A (es) 1969-10-29 1973-02-07
GB1338169A (en) 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
GB1400319A (en) 1972-04-20 1975-07-16 Smith Kline French Lab Pharmaceutical compositions
GB1398426A (en) 1972-09-05 1975-06-18 Smith Kline French Lab Heterocyclic substituted guanidines
GB1397436A (en) 1972-09-05 1975-06-11 Smith Kline French Lab Heterocyclic n-cyanoguinidines
GB1421999A (en) 1973-02-08 1976-01-21 Smith Kline French Lab Heterocyclic containing sulphoxides
GB1419994A (en) 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them
GB1421792A (en) 1973-05-17 1976-01-21 Smith Kline French Lab Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them
GB1497260A (en) 1974-06-28 1978-01-05 Smith Kline French Lab Guanidine derivatives
GB1533379A (en) 1974-09-02 1978-11-22 Smith Kline French Lab Process for the preparation of heterocyclic substituted ureas
GB1533380A (en) 1974-09-02 1978-11-22 Smith Kline French Lab Process for the preparation of heterocyclic substituted thioureas and h-cyanoguanidines
GB1531231A (en) 1974-09-02 1978-11-08 Smith Kline French Lab Process for the production of cyanoguanidine derivatives
GB1574214A (en) 1976-03-11 1980-09-03 Smith Kline French Lab Amidines
NZ186965A (en) * 1977-04-20 1980-02-21 Ici Ltd Guanidino derivatives and pharmaceutical compositions
US4165378A (en) * 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
ATE1353T1 (de) * 1978-05-24 1982-08-15 Imperial Chemical Industries Plc Anti-sekretion thiadiazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.

Also Published As

Publication number Publication date
ATE1353T1 (de) 1982-08-15
IE790902L (en) 1979-11-24
PL118387B1 (en) 1981-09-30
CS207791B2 (en) 1981-08-31
EP0006679B1 (en) 1982-07-21
CA1124729A (en) 1982-06-01
FI791656A (fi) 1979-11-25
US4332949A (en) 1982-06-01
JPS54160376A (en) 1979-12-19
NO791710L (no) 1979-11-27
ES484150A1 (es) 1980-04-16
IL57388A0 (en) 1979-09-30
AU529253B2 (en) 1983-06-02
PT69651A (en) 1979-06-01
NZ190448A (en) 1980-12-19
ES484149A1 (es) 1980-04-16
CS207790B2 (en) 1981-08-31
AU4711479A (en) 1979-11-29
PL215764A1 (es) 1980-06-16
IE48221B1 (en) 1984-10-31
DD143772A5 (de) 1980-09-10
SU1037839A3 (ru) 1983-08-23
DE2963363D1 (en) 1982-09-09
EP0006679A1 (en) 1980-01-09
ZA792202B (en) 1980-05-28
US4242350A (en) 1980-12-30
GR73611B (es) 1984-03-26
HU179492B (en) 1982-10-28
DK209079A (da) 1979-11-25

Similar Documents

Publication Publication Date Title
ES484150A1 (es) Procedimiento para la preparacion de derivados de tiadiazol
ES468985A1 (es) Procedimiento para preparar derivados de guanidina
ES8609247A1 (es) Un procedimiento para la preparacion de derivados del indol
HUT40668A (en) Process for preparing new benzoxazole and amine derivatives and pharmaceutical compositions containing such compounds
PH20468A (en) Novel pharmaceutically active di-esters of 3,5-dicarboxy-4-substituted-pyridines and pyrans
GB2001624A (en) Guanidine derivatives
DE2966646D1 (en) Antisecretory branched-chain heterocyclic guanidine derivatives, processes for their manufacture, intermediates, and pharmaceutical compositions containing said derivatives
NO894663D0 (no) Renin-hemmende aminodiolderivater.
ES8305751A1 (es) Procedimiento para la obtencion de derivados del ditiol-1,2 ilideno-3 amonio.